Related Experiment Video
Updated: Jul 3, 2025
Counting Proteins in Single Cells with Addressable Droplet Microarrays
Published on: July 6, 2018
Monitoring APOBEC3A protein levels in human cancer cells
Alexandra Dananberg1, John Maciejowski1
1Molecular Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
Abstract:
The APOBEC3 family of cytosine deaminases, which target single-stranded DNA and RNA of viruses and retroelements as part of the innate immune defense, generate mutations in many human cancers. Although the APOBEC3A paralog is a major endogenous source of these mutations, low APOBEC3A mRNA levels and protein abundance have hampered functional characterization. Extensive homology across APOBEC3 paralogs have further challenged the development of specific detection reagents. Here, we describe the isolation and use of monoclonal antibodies with specificity for APOBEC3A and the APOBEC3A/APOBEC3B/APOBEC3G proteins. We provide protocols and technical advice for detection and measurement of APOBEC3A protein across human cancer cell lines using standard immunoblotting and immunofluorescence protocols.
Insights
Researchers developed specific antibodies to detect APOBEC3A, a key enzyme causing mutations in human cancers. This breakthrough enables better understanding of APOBEC3A
Area of Science:
- Biochemistry
- Molecular Biology
- Immunology
Background:
- The APOBEC3 family of enzymes are crucial for innate immunity by targeting viral DNA and RNA.
- These enzymes, particularly APOBEC3A, are implicated in generating mutations observed in various human cancers.
- Low APOBEC3A expression and challenges in developing specific antibodies have hindered its functional study.
Purpose of the Study:
- To develop and validate specific monoclonal antibodies for APOBEC3A detection.
- To enable the functional characterization of APOBEC3A in cancer mutational processes.
- To provide reliable methods for measuring APOBEC3A protein levels in cancer cell lines.
Main Methods:
- Isolation and characterization of monoclonal antibodies targeting APOBEC3A.
- Application of immunoblotting and immunofluorescence techniques.
- Detection and measurement of APOBEC3A protein in human cancer cell lines.
Main Results:
- Successfully generated monoclonal antibodies with specificity for APOBEC3A.
- Demonstrated the utility of these antibodies for detecting APOBEC3A protein.
- Established protocols for APOBEC3A detection using standard biochemical assays.
Conclusions:
- Specific antibodies for APOBEC3A are now available, overcoming previous limitations.
- These tools facilitate the study of APOBEC3A's role in cancer mutagenesis.
- The provided protocols will aid researchers in measuring APOBEC3A protein levels.
